(Unsplash)

Expert panel recommends Canada implement single-payer pharmacare plan

Plan wouldn’t be in place for at least 10 years

An expert panel is calling for the federal government to work with the provinces and territories to create a single-payer national pharmacare plan to cover every Canadian.

Eric Hoskins, Ontario’s former health minister, released the findings in Ottawa, giving advice on how to address the country’s patchwork of private and public prescription-drug plans.

Canada has a variety of drug plans administered by provinces, mainly for children, seniors and people on social assistance.

Other plans managed by the federal government cover other groups, such as Indigenous people and members of the military, while private insurance fills the gaps for some.

Hoskins’ council is recommending a new drug agency that would be responsible for developing a national list of prescription drugs, known as a formulary, beginning with common or so-called essential medicines by Jan. 1, 2022.

It also recommends that the initial formulary expand to a “fully comprehensive formulary” no later than Jan. 1, 2027.

“Our council has heard the stories of thousands of Canadians and listened to a wide range of perspectives,” Hoskins said in the report, entitled “A Prescription for Canada: Achieving Pharmacare for All.”

“The time for universal, single-payer, public pharmacare has come … Let’s complete the unfinished business of universal health care. That can be our promise, and our legacy, to each other and to all future generations.”

The council says universal, single-payer public pharmacare will provide access to prescription medications for all Canadians, including an estimated one in five Canadians who are either uninsured or underinsured.

The plan, once implemented, will result in an estimated $5 billion in savings, the council said, adding that savings for Canadians will be on average $350 per year.

In its last budget, the Liberal government pledged to create a new agency to buy drugs in bulk and cut Canadian medication costs as the first step toward a national drug plan.

ALSO READ: B.C. Pharmacare expanding use of ‘biosimilar’ drugs to save money

ALSO READ: Canada needs new agency to oversee pharmacare program, panel says

The Canadian Press


Like us on Facebook and follow us on Twitter.

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Central zone down to 16 active COVID-19 cases

Alberta Health Services’ central zone is down to 16

Sylvan Lake woman says Town’s response time to concerns isn’t enough

Glenda Jackman says it took almost a month for the Town to act on her complaint about a playground

Central zone down to 19 active COVID-19 cases on Thursday

Provincially, 158 new COVID-19 cases were identified

Alberta politicians reject throne speech

Premier Kenney disapointed with lack of support for Alberta energy

Central zone has 20 active cases of COVID-19

Province identified 143 new cases across Alberta on Wednesday

Alberta’s top health official says province is not in a second wave of COVID-19

Dr. Deena Hinshaw said Thursday that Alberta had identified 158 new cases in the province

8 charged, $260K in drugs and cash seized in massive Alberta drug bust

Eight people are facing 33 charges in what police have dubbed Project Incumbent

Millet Agriplex to become a hub for indoor soccer

Wetaskiwin Soccer Club will be operating out of the Millet Agriplex this season.

‘We’re losing what makes the Parkland so distinctive,” conservation specialist says

The Lacombe district will lose two sites with provincial park status: JJ Collett and the Narrows

Ermineskin Kindergarten has a confirmed case of COVID-19

The school has shut down and Cohort 2 is in self-isolation

Hundreds die from opioid overdoses in Alberta as COVID-19 pandemic hit

Jason Luan said the province is not alone in seeing a rise in deaths,

Wetaskiwin/ Camrose RCMP conduct a joint forces initiative with Camrose Police Service

The multifaceted joint forces initiative with on Sept. 23, 2020 proved very successful.

Most Read